1. Home
  2. ANTX vs ATCH Comparison

ANTX vs ATCH Comparison

Compare ANTX & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AN2 Therapeutics Inc.

ANTX

AN2 Therapeutics Inc.

HOLD

Current Price

$1.05

Market Cap

31.2M

Sector

Health Care

ML Signal

HOLD

Logo AtlasClear Holdings Inc.

ATCH

AtlasClear Holdings Inc.

HOLD

Current Price

$0.23

Market Cap

34.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANTX
ATCH
Founded
2017
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.2M
34.9M
IPO Year
2022
2024

Fundamental Metrics

Financial Performance
Metric
ANTX
ATCH
Price
$1.05
$0.23
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$2.00
N/A
AVG Volume (30 Days)
65.6K
4.3M
Earning Date
02-26-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
37.23
N/A
EPS
N/A
0.06
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$3.94
Revenue Growth
N/A
N/A
52 Week Low
$1.00
$0.14
52 Week High
$1.49
$7.25

Technical Indicators

Market Signals
Indicator
ANTX
ATCH
Relative Strength Index (RSI) 43.31 42.38
Support Level $1.03 $0.17
Resistance Level $1.16 $0.24
Average True Range (ATR) 0.06 0.02
MACD -0.00 0.00
Stochastic Oscillator 33.33 29.70

Price Performance

Historical Comparison
ANTX
ATCH

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.

About ATCH AtlasClear Holdings Inc.

AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.

Share on Social Networks: